A simple flow-volume device for measuring ventilatory function in the field. Results on workers exposed to low levels of toluene diisocyanate.

PubWeight™: 1.67‹?› | Rank: Top 3%

🔗 View Article (PMID 5767597)

Published in Am Rev Respir Dis on April 01, 1969

Authors

J M Peters, J Mead, W F Van Ganse

Articles by these authors

How proteolysis drives the cell cycle. Science (1996) 8.59

A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B. Cell (1995) 8.34

Anaphase initiation in Saccharomyces cerevisiae is controlled by the APC-dependent degradation of the anaphase inhibitor Pds1p. Genes Dev (1996) 8.28

Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest (1999) 6.99

Significance of the relationship between lung recoil and maximum expiratory flow. J Appl Physiol (1967) 5.87

The PPARalpha-leukotriene B4 pathway to inflammation control. Nature (1996) 5.14

Two distinct pathways remove mammalian cohesin from chromosome arms in prophase and from centromeres in anaphase. Cell (2000) 5.10

Stress distribution in lungs: a model of pulmonary elasticity. J Appl Physiol (1970) 4.38

Splitting the chromosome: cutting the ties that bind sister chromatids. Science (2000) 4.20

Mitotic regulation of the APC activator proteins CDC20 and CDH1. Mol Biol Cell (2000) 4.01

Measurement of the separate volume changes of rib cage and abdomen during breathing. J Appl Physiol (1967) 3.95

Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint. J Cell Biol (2001) 3.86

Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem (1998) 3.78

APC-mediated proteolysis of Ase1 and the morphogenesis of the mitotic spindle. Science (1997) 3.73

Securin is required for chromosomal stability in human cells. Cell (2001) 3.71

Characterization of vertebrate cohesin complexes and their regulation in prophase. J Cell Biol (2000) 3.70

Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J Biol Chem (1999) 3.57

Resistance of central and peripheral airways measured by a retrograde catheter. J Appl Physiol (1967) 3.53

Exposure to residential electric and magnetic fields and risk of childhood leukemia. Am J Epidemiol (1991) 3.49

An NSF-like ATPase, p97, and NSF mediate cisternal regrowth from mitotic Golgi fragments. Cell (1995) 3.40

Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex. Cell (2001) 3.36

Proportional mortality among vinyl-chloride workers. Lancet (1974) 3.36

Cohesin cleavage by separase required for anaphase and cytokinesis in human cells. Science (2001) 3.35

Childhood leukemia and parents' occupational and home exposures. J Natl Cancer Inst (1987) 3.03

Dispersal of first "workers" in social wasps: causes and implications of an alternative reproductive strategy. Proc Natl Acad Sci U S A (1998) 2.96

Effects of maternal smoking during pregnancy and environmental tobacco smoke on asthma and wheezing in children. Am J Respir Crit Care Med (2001) 2.82

Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex. Nature (1999) 2.63

Identification of a cullin homology region in a subunit of the anaphase-promoting complex. Science (1998) 2.61

Cell cycle- and cell growth-regulated proteolysis of mammalian CDC6 is dependent on APC-CDH1. Genes Dev (2000) 2.58

Occupational exposures of parents of children with acute nonlymphocytic leukemia: a report from the Childrens Cancer Study Group. Cancer Res (1989) 2.55

Expression of the CDH1-associated form of the anaphase-promoting complex in postmitotic neurons. Proc Natl Acad Sci U S A (1999) 2.54

Activation of the human anaphase-promoting complex by proteins of the CDC20/Fizzy family. Curr Biol (1998) 2.50

Elasticity of human lungs in relation to age. J Appl Physiol (1968) 2.47

Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice. J Cell Biol (2001) 2.41

The formation of Golgi stacks from vesiculated Golgi membranes requires two distinct fusion events. Cell (1995) 2.35

The occupational and environmental health history. JAMA (1981) 2.34

Scc1/Rad21/Mcd1 is required for sister chromatid cohesion and kinetochore function in vertebrate cells. Dev Cell (2001) 2.30

Environmental tobacco smoke and absenteeism related to respiratory illness in schoolchildren. Am J Epidemiol (2003) 2.23

Chronic effect of fire fighting on pulmonary function. N Engl J Med (1974) 2.20

DDT and related compounds and risk of pancreatic cancer. J Natl Cancer Inst (1992) 2.16

Job activity and colon cancer risk. Am J Epidemiol (1984) 2.15

Worker-sponsored survey for asbestosis: detection of occupational lung disease without a control group. Arch Environ Health (1973) 2.12

Genetic support for the evolutionary theory of reproductive transactions in social wasps. Proc Biol Sci (2000) 2.11

A simplified measurement of respiratory resistance by forced oscillation. J Appl Physiol (1970) 2.11

Identification of a novel ubiquitin-conjugating enzyme involved in mitotic cyclin degradation. Curr Biol (1996) 2.10

Chlorinated hydrocarbon solvents: substituting our way toward human carcinogenicity. Am J Ind Med (1993) 2.10

Early thalamic lesions in patients with sleep-potentiated epileptiform activity. Neurology (2012) 2.08

Maternal smoking during pregnancy, environmental tobacco smoke exposure and childhood lung function. Thorax (2000) 2.06

Acute respiratory effects in workers exposed to low levels of toluene diisocyanate (TDI). Arch Environ Health (1968) 2.04

Variability of maximum expiratory flow-volume curves. J Appl Physiol (1974) 2.03

Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner. J Biol Chem (1998) 2.00

Air pollution and bronchitic symptoms in Southern California children with asthma. Environ Health Perspect (1999) 1.98

Oat cell lung cancer in selected occupations: a case-control study. J Occup Med (1978) 1.92

Dysanapsis in normal lungs assessed by the relationship between maximal flow, static recoil, and vital capacity. Am Rev Respir Dis (1980) 1.88

The RING-H2 finger protein APC11 and the E2 enzyme UBC4 are sufficient to ubiquitinate substrates of the anaphase-promoting complex. Proc Natl Acad Sci U S A (2000) 1.82

The lung's "quiet zone". N Engl J Med (1970) 1.80

Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease. Gut (2006) 1.77

Nonperiodic activity of the human anaphase-promoting complex-Cdh1 ubiquitin ligase results in continuous DNA synthesis uncoupled from mitosis. Mol Cell Biol (2000) 1.74

The role of Kupffer cell oxidant production in early ethanol-induced liver disease. Free Radic Biol Med (2001) 1.69

Frequency dependence of flow resistance in patients with obstructive lung disease. J Clin Invest (1968) 1.65

Respiratory effects of relocating to areas of differing air pollution levels. Am J Respir Crit Care Med (2001) 1.64

The casein kinase I family in Wnt signaling. Dev Biol (2001) 1.63

Lymphocyte transformation in chronic pulmonary berylliosis. Lancet (1972) 1.63

Pulmonary function in firefighters: acute changes in ventilatory capacity and their correlates. Br J Ind Med (1979) 1.61

Respiratory impairment in workers exposed to "safe" levels of toluene diisocyanate (TDI). Arch Environ Health (1970) 1.61

Sedation for pediatric endoscopic procedures. J Pediatr Gastroenterol Nutr (2000) 1.59

Lung function in fire fighters, I: a three year follow-up of active subjects. Am J Public Health (1977) 1.58

The effects of ambient air pollution on school absenteeism due to respiratory illnesses. Epidemiology (2001) 1.57

Mechanisms determining residual volume of the lungs in normal subjects. J Appl Physiol (1967) 1.55

A conserved cyclin-binding domain determines functional interplay between anaphase-promoting complex-Cdh1 and cyclin A-Cdk2 during cell cycle progression. Mol Cell Biol (2001) 1.53

Prevalence rates of chronic non-specific respiratory disease in fire fighters. Am Rev Respir Dis (1974) 1.52

Crystal structure of the APC10/DOC1 subunit of the human anaphase-promoting complex. Nat Struct Biol (2001) 1.51

Adaptive increase in pyruvate dehydrogenase kinase 4 during starvation is mediated by peroxisome proliferator-activated receptor alpha. Biochem Biophys Res Commun (2001) 1.50

PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance. Diabetes (2001) 1.50

Glutathione-S-transferase (GST) P1, GSTM1, exercise, ozone and asthma incidence in school children. Thorax (2008) 1.48

PPARbeta/delta selectively induces differentiation and inhibits cell proliferation. Cell Death Differ (2006) 1.47

Flow-volume curves during quiet breathing, maximum voluntary ventilation, and forced vital capacities in patients with obstructive lung disease. Scand J Respir Dis (1967) 1.47

Pulmonary ventilation measured from body surface movements. Science (1967) 1.46

Cigarette smoking and pulmonary diffusing capacity. (Transfer factor). Am Rev Respir Dis (1972) 1.44

Leukaemia in workers exposed to electrical and magnetic fields. Lancet (1982) 1.43

Factors influencing pulmonary resistance. J Appl Physiol (1970) 1.41

Relative contributions of large and small airways to flow limitation in normal subjects before and after atropine and isoproterenol. J Clin Invest (1977) 1.41

Chronic pulmonary function loss from exposure to toluene diisocyanate. Br J Ind Med (1977) 1.40

Pulmonary effects of exposures in silicon carbide manufacturing. Br J Ind Med (1984) 1.39

Multiple myeloma in cosmetologists. Am J Ind Med (1982) 1.38

Functional significance of the area of apposition of diaphragm to rib cage [proceedings]. Am Rev Respir Dis (1979) 1.38

Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype. J Biol Chem (1999) 1.36

Mechanical interaction between the diaphragm and rib cage. J Appl Physiol (1973) 1.36

Contribution of compliance of airways to frequency-dependent behavior of lungs. J Appl Physiol (1969) 1.35

Resistance of the total respiratory system in healthy infants and infants with bronchiolitis. Pediatrics (1969) 1.35

Peroxisome proliferator-activated receptor-alpha regulates lipid homeostasis, but is not associated with obesity: studies with congenic mouse lines. J Biol Chem (2001) 1.34

Characterization of the DOC1/APC10 subunit of the yeast and the human anaphase-promoting complex. J Biol Chem (1999) 1.34

Organ weights and water levels of the rat following reduced food intake. J Nutr (1966) 1.33

Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor alpha. J Biol Chem (1997) 1.33

Tobacco, alcohol, diet, occupation, and carcinoma of the esophagus. Cancer Res (1988) 1.33

Daily relaxation response breaks in a working population: II. Effects on blood pressure. Am J Public Health (1977) 1.33

Epidemiology of toluene diisocyanate (TDI)-induced respiratory disease. Environ Health Perspect (1975) 1.33

Mechanism of action of the nongenotoxic peroxisome proliferators: role of the peroxisome proliferator-activator receptor alpha. J Natl Cancer Inst (1998) 1.32